Dan Ollendorf

Advanced Therapies: The Price is Right?

Health technology assessments find that many cell and gene therapies are more cost effective than existing treatments and managing symptoms with palliative care. But are healthcare systems and manufacturers ready to embrace evidence-based pricing to lessen the impact of upfront costs?